Skip to main content

Table 3 Pricing of anti-malarial drugs in Burundi, by sector

From: Anti-malarial market and policy surveys in sub-Saharan Africa

Survey area

Number of outlets

Median price, US$ (range)

Government/Public Sector

  

   AS+AQ

31

0.16 (0.00–0.16)

   Halofantrine

2

8.90 (8.35–9.44)

   Quinine injection

20

0.24 (0.00–0.48)

Charity

  

   AS+AQ

15

0.16 (0.08–2.42)

   Quinine injection

9

0.32 (0.16–0.81)

   Quinine tablets

1

1.66 (0.51–2.58)

Private

  

   AQ

1

0.32 (0.32–0.32)

   AM+LUM

2

0.60 (0.40–0.81)

   AS+AQ

7

0.40 (0.17–2.82)

   DHA+PQ

1

2.82 (2.82–2.82)

   Dihydroartemisinin

1

4.84 (4.84–4.84)

   Dihydroartemisinin*

3

4.03 (4.03–4.84)

   Halofantrine

3

9.68 (8.47–9.68)

   Halofantrine*

11

9.68 (7.66–11.29)

   Quinine injection

17

0.40 (0.24–1.61)

   Quinine tablets

29

1.61 (0.32–3.39)

  1. For tablets the price is for a course; for injections is for a single injection. The price per course is neither for adults nor for adolescents or children. Often when an adult treatment is not available; multiple adolescent or child doses are given to supplement and vice-versa.
  2. *These were found in stand-alone pharmacies that were not attached to, or part of, any health facility.
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us